The spectrum of antibiotic prescribing during COVID-19 pandemic: a systematic literature review

SH Al-Hadidi, H Alhussain, H Abdel Hadi… - Microbial Drug …, 2021 - liebertpub.com
Objectives: Over the last decades, there has been a significant increase in antimicrobial
prescribing and consumption associated with the development of patients' adverse events …

Antiandrogens as Therapies for COVID-19: A Systematic Review

M Cani, S Epistolio, G Dazio, M Modesti, G Salfi… - Cancers, 2024 - mdpi.com
Simple Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic recently represented an unexpected global issue. Due to its rapid spread and …

Cancer treatment and research during the COVID-19 pandemic: experience of the first 6 months

B de Las Heras, KS Saini, F Boyle, F Ades… - Oncology and …, 2020 - Springer
Abstract The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact
on patients with underlying malignancy. In this article, we summarize emerging data related …

The impact of SARS-CoV-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder …

M Ferro, F Del Giudice, G Carrieri, GM Busetto… - Cancers, 2021 - mdpi.com
Simple Summary The worldwide COVID-19 emergency has had an important impact on
healthcare systems with the need to assist infected patients and also treat non-deferrable …

Molecular targeted therapies in metastatic prostate cancer: recent advances and future challenges

C Sorrentino, E Di Carlo - Cancers, 2023 - mdpi.com
Simple Summary Recent studies have highlighted the importance of molecular targeted
therapies in metastatic castration-resistant prostate cancer. These therapies, which aim to …

Plasmatic MicroRNAs and treatment outcomes of patients with metastatic castration-resistant prostate Cancer: a hospital-based Cohort Study and in Silico Analysis

J Silva, V Tavares, A Afonso, J Garcia… - International Journal of …, 2023 - mdpi.com
Prostate cancer (PCa) is one of the most common malignancies among men worldwide.
Inevitably, all advanced PCa patients develop metastatic castration-resistant prostate cancer …

COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males

FI Scroppo, E Costantini, A Zucchi, E Illiano… - Journal of basic and …, 2022 - degruyter.com
Objectives We want to evaluate the possible presence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) in semen samples and semen quality, looking for a possible …

Evaluation of the current therapeutic approaches for COVID-19: a systematic review and a meta-analysis

Z Abdelrahman, Q Liu, S Jiang, M Li, Q Sun… - Frontiers in …, 2021 - frontiersin.org
Background: Limited data on the efficacy and safety of currently applied COVID-19
therapeutics and their impact on COVID-19 outcomes have raised additional concern …

m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer

Y Liang, X Zhang, C Ma, J Hu - Cancers, 2022 - mdpi.com
Simple Summary Recurrence and metastatic progression always lead to dismal outcomes in
prostate cancer (PCa). There is no reliable biomarker for the prediction of recurrence and …

Increased hospitalization and mortality from COVID-19 in prostate cancer patients

D Chakravarty, P Ratnani, S Sobotka, D Lundon… - Cancers, 2021 - mdpi.com
Simple Summary The COVID-19 pandemic has had a remarkable and insurmountable effect
on humankind. The SARS-Co-V2 infection results in a life-threatening situation, particularly …